Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill — Chapel Hill, North Carolina

Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill is a clinical research site located in Chapel Hill, North Carolina, United States 27514.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill has participated in 1 clinical trials.

Therapeutic areas: Relapsed or Refractory Multiple Myeloma.

Sponsors: Incyte Corporation.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill?

Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill conducted?

Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill has 1 clinical trials on record. Their work covers Relapsed or Refractory Multiple Myeloma.

Is Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill accredited by Crixeo Health?

Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lineberger Comprehensive Cancer Center At University of North Carolina Chapel Hill?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.